Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders
- 2 October 2004
- journal article
- clinical trial
- Published by Elsevier in Controlled Clinical Trials
- Vol. 25 (5), 472-492
- https://doi.org/10.1016/j.cct.2004.08.003
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Hepatitis C. Development of new drugs and clinical trials: Promises and pitfalls. Summary of an AASLD hepatitis single topic conference, Chicago, IL, February 27-March 1, 2003Hepatology, 2004
- Monitoring of viral levels during therapy of hepatitis CHepatology, 2002
- Introduction to therapy of hepatitis CHepatology, 2002
- Side effects of therapy of hepatitis C and their managementHepatology, 2002
- Natural history of chronic hepatitis CHepatology, 2002
- A Model to Predict Survival in Patients With End–Stage Liver DiseaseHepatology, 2001
- Risk factors and the effect of interferon therapy in the development of hepatocellular carcinoma: A multivariate analysis in 343 patientsJournal of Gastroenterology and Hepatology, 1997
- The Long–Term Pathological Evolution of Chronic Hepatitis CHepatology, 1996
- Interim analysis: The alpha spending function approachStatistics in Medicine, 1994
- Discrete Sequential Boundaries for Clinical TrialsBiometrika, 1983